Medicine
Mirvaso 0.5% gel
Mirvaso 0.5% gel is a prescription medicine containing Brimonidine for topical use, marketed by Galderma Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and…
Key facts
- Active ingredient (INN)
- Brimonidine
- Brand
- Mirvaso
- Strength
- 0.5%
- Dosage form
- Gel
- Route
- Topical
- Packs
- 1 bottle
- Marketing authorisation holder
- Galderma Laboratories
- Manufacturer
- Galderma Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D11AX21 Brimonidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 August 2013
- Identifiers
- RxCUI 1437707, 1437709DailyMed set ID f6a4353f-ae69-4214-901f-e5d42a6fbde7NDC 0299-5980Application NDA204708
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, pump in 1 carton / 30 g in 1 bottle, pump | 0299-5980-35 | Galderma Laboratories | 23 August 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Brimonidine 0.5% gel.
Other strengths and forms of Brimonidine
Clinical summary
Brimonidine is an alpha-adrenergic agonist indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. It is available as eye drops, gel and ophthalmic solution for topical use. MedsAcross supplies Brimonidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BrimonidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ALPHAGAN P prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Mirvaso: European public assessment report (EPAR) · European Medicines Agency
Need Mirvaso 0.5% gel for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.